Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
W2505 in Erectile Dysfunction
NCT07859202Phase 3Not yet recruiting
- Sponsor
- GL Pharm Tech Corp
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 3 trial of W2505 in erectile dysfunction (ED), sponsored by GL Pharm Tech Corp. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
W2505
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07859202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07859202.